A phase II feasibility study of cytarabine and idarubicin combination in relapsed or refractory adult acute lymphoblastic leukemia

被引：0
|
作者：
Hafeez, M. [1 ]
Shaharyar, A. [1 ]
Zia, N. [1 ]
Rasheed, H. [1 ]
机构：
[1] King Edward Med Univ, Mayo Hosp, Lahore, Pakistan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18002
引用
收藏
页数：1
相关论文
共 50 条
  • [41] COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Spassov, B.
    Balatzenko, G.
    Angelova, S.
    Toshkov, S.
    Guenova, M.
    Arnaudov, G.
    Mihaylov, G.
    HAEMATOLOGICA, 2015, 100 : 377 - 377
  • [42] Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia
    Liedtke, Michaela
    Dunn, Tamara
    Dinner, Shira
    Coutre, Steven E.
    Berubea, Caroline
    Gotlib, Jason
    Patel, Samit
    Medeiros, Bruno
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1441 - 1445
  • [43] Combination of topotecan with cytarabine or etoposide in patients with refractory or relapsed acute myeloid leukemia: Results of a randomized phase I/II study.
    Vey, N
    Kantarjian, H
    Beran, M
    O'Brien, S
    Cortes, J
    Giles, FJ
    Koller, C
    Estey, E
    BLOOD, 1998, 92 (10) : 235A - 235A
  • [44] A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia
    Lowenthal, RM
    Bradstock, KF
    Matthews, JP
    Bishop, JF
    Juneja, S
    Cobcroft, R
    Eliadis, P
    Enno, A
    Gill, D
    Herrmann, RP
    Manoharan, A
    Page, FJ
    Rooney, KF
    Rosenfeld, D
    Seldon, M
    Taylor, KM
    Wolf, MM
    Young, GAR
    LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) : 501 - 510
  • [45] A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Daver, Naval
    Boumber, Yanis
    Kantarjian, Hagop
    Ravandi, Farhad
    Cortes, Jorge
    Rytting, Michael E.
    Kawedia, Jitesh D.
    Basnett, Jordan
    Culotta, Kirk S.
    Zeng, Zhihong
    Lu, Hongbo
    Richie, Mary Ann
    Garris, Rebecca
    Xiao, Lianchun
    Liu, Wenbin
    Baggerly, Keith A.
    Jabbour, Elias
    O'Brien, Susan
    Burger, Jan
    Bendall, Linda J.
    Thomas, Deborah
    Konopleva, Marina
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2704 - 2714
  • [46] Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia in Adult Patients
    Oriol, Albert
    ACTA HAEMATOLOGICA, 2015, 133 (01) : 89 - 90
  • [47] Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study
    Karol, Seth E.
    Alexander, Thomas B.
    Budhraja, Amit
    Pounds, Stanley B.
    Canavera, Kristin
    Wang, Lei
    Wolf, Joshua
    Klco, Jeffery M.
    Mead, Paul E.
    Das Gupta, Soumyasri
    Kim, Su Y.
    Salem, Ahmed Hamed
    Palenski, Tammy
    Lacayo, Norman J.
    Pui, Ching-Hon
    Opferman, Joseph T.
    Rubnitz, Jeffrey E.
    LANCET ONCOLOGY, 2020, 21 (04): : 551 - 560
  • [48] A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia
    Rosen, PJ
    Rankin, C
    Head, DR
    Boldt, DH
    Luthardt, FW
    Norwood, T
    Pugh, RP
    Karanes, C
    Appelbaum, FR
    LEUKEMIA RESEARCH, 2000, 24 (03) : 183 - 187
  • [49] Daunorubicin, cytarabine and fludarabine (DAF) for the treatment of relapsed/refractory acute myeloid leukemia. Phase II study by the polish adult leukemia group (PALG)
    Holowiecki, J
    Grosicki, S
    Krzemien, S
    Skotnicki, A
    Warzecha, K
    Zdziarska, B
    Stella-Holowiecka, B
    Krawczyk-Kulis, M
    Kopera, M
    Wojciechowska, M
    BLOOD, 2004, 104 (11) : 210B - 210B
  • [50] Phase I/II Trial of Nanomolecular Liposomal Annamycin in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
    Wetzler, Meir
    Thomas, Debora A.
    Wang, Eunice S.
    Shepard, Robert
    Ford, Laurie A.
    Heffner, Thompson L.
    Parekh, Samir
    Andreeff, Michael
    O'Brien, Susan
    Kantarjian, Hagop M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2013, 13 (04): : 430 - 434
12345